Progesterone vaginal - Besins Healthcare

Drug Profile

Progesterone vaginal - Besins Healthcare

Alternative Names: Utrogestan

Latest Information Update: 05 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Besins Healthcare
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Amenorrhoea; Breast disorders; Breast pain; Endometriosis; Female infertility; Menopausal syndrome; Menstruation disorders; Premenstrual syndrome; Preterm labour; Spontaneous abortion

Most Recent Events

  • 18 Sep 2017 Besins Healthcare initiates enrolment in a phase III trial for postmenopausal disorder in Austria (EudraCT:2016-004386-12)
  • 08 May 2017 The Scottish Medicines Consortium approves progesterone vaginal in women for supplementation of the luteal phase during Assisted Reproductive Technology (ART) cycles
  • 24 Aug 2015 Ewha Womans University and Han Wha Pharma plan a phase III trial for Preterm labour (Prevention) in South Korea (NCT02304237)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top